
FEELM, the flagship vaporization technology platform owned by SMOORE, the world's largest electronic cigarette manufacturer, has been awarded a tobacco monopoly production enterprise license.
In early 2022, China introduced new national standards for electronic cigarettes, requiring companies manufacturing these devices to obtain production licenses. Three SMOORE factories (two of which operate under the FEELM brand) have been granted these licenses, with FEELM also receiving official approval to produce electronic cigarettes as part of its physical business.
SMOORE welcomes the new policy framework that ensures all electronic cigarette manufacturers operate in compliance with the law. SMOORE's goal is to continue utilizing science and technology as the driving force behind its business model, actively promoting the long-term sustainability of the industry, and supporting its global customer base.
FEELM's products are now available in more than 50 countries worldwide. In 2022, the company will launch two innovative disposable e-cigarette devices: the FEELM Max and the world's first super-thin e-cigarette device, the FEELM Air. These new products will be sold in markets across the United States, Europe, Africa, and elsewhere, with the goal of solidifying FEELM's position as a global technological leader in the e-cigarette market.
FEELM currently has an annual production capacity of 2 billion pods and boasts the industry's first fully automated production line, which can manufacture over 7,200 aerosolizers per hour. Their production process places a strong emphasis on continuously improving the electronic cigarette experience for customers.
Regarding FEELM: as the flagship technology brand of SMOORE, FEELM is a global leader in providing closed-system electronic cigarette solutions. Utilizing world-leading ceramic coil heating technology, FEELM combines authentic flavor replication techniques with innovative electronic technology to deliver the ultimate sensation and high-quality electronic cigarette experience.
Regarding SMOORE: SMOORE is a global leader in providing electronic cigarette technology solutions, including the manufacturing of electronic cigarette equipment and components for HNB products based on ODM. They possess advanced research and development technology, strong manufacturing capability, a wide range of product portfolios, and a diverse customer base.
According to data from Frost & Sullivan, SMOORE is the largest electronic cigarette device manufacturer in the world in terms of revenue, accounting for 22.8% of the total global market share in 2021. Its global market share is greater than the sum of the second through fifth ranking companies.
Statement
This article is compiled from third-party information and is intended solely for industry professionals to share and learn from.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is only intended for industry-related communication and research.
Due to limitations in translation abilities, the translated article may not fully express the same content as the original. Therefore, please refer to the original article for accuracy.
In regards to any statements or positions related to domestic issues, matters involving Hong Kong, Macau or Taiwan, as well as foreign affairs, 2FIRSTS aligns completely with the Chinese government.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









